Skip to main content
EB

Endure Beyond

Endure Beyond secures guaranteed race entries for endurance athletes who commit to fundraising for cancer research. The platform connects runners with events and channels their donations to leading cancer research organizations, including the American Cancer Society.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Individuals seeking to participate in endurance races often face challenges securing race entries, particularly for popular events. Simultaneously, there is a desire to leverage athletic pursuits for charitable causes, specifically supporting cancer research, but a streamlined mechanism for this integration is lacking.

Solution

Endure Beyond facilitates participation in endurance races by providing guaranteed entry to select events for individuals who commit to fundraising targets. The platform acts as an intermediary, connecting runners with races and channeling their fundraising efforts towards cancer research initiatives. This model transforms athletic endeavors into a direct funding stream for research organizations. Donations are aggregated and disbursed annually to partner foundations, with a significant portion directed to the American Cancer Society.

Target Audience

The primary audience includes runners and athletes interested in participating in endurance events while simultaneously contributing to cancer research, as well as individuals seeking to honor or support those affected by cancer.

Features

  • Partnership agreements with endurance race organizers to secure guaranteed participant slots.
  • Commitment-based fundraising model where race entry is contingent on achieving a defined donation threshold.
  • Centralized donation processing and disbursement to designated cancer research foundations.
  • Direct financial support to the American Cancer Society, a leading cancer research organization.
  • Allocation of a portion of funds to a specific ovarian cancer lectureship at Anschutz Medical Campus.
  • Tax-exempt charitable organization status (501(c)(3)) for donor contributions.
This profile is AI-generated and may contain inaccuracies.